Skip to content
Search

Latest Stories

GPhC to review revalidation process, seeks pharmacy professionals’ feedback

GPhC to review revalidation process, seeks pharmacy professionals’ feedback

 Grant Thornton appointed to support GPhC in reviewing the revalidation process and framework

The General Pharmaceutical Council (GPhC) is inviting pharmacy technicians and pharmacists who have undergone revalidation since October 2022 to share their experiences by participating in a survey.


Additionally, pharmacy professionals are encouraged to provide feedback on the impact of revalidation and offer comments and suggestions for improving the process.

The Council said: “The purpose of this survey is to ensure that the current revalidation process is effective and meets the needs of professionals and the public.”

To support this review, the GPhC has appointed the consultancy firm Grant Thornton, which will also help in identifying any gaps and determining areas that may require further development.

“The Grant Thornton review will contribute to the development of potential changes to the revalidation framework,” it said.

However, the Council noted that no changes will be introduced before June 2025 and any new proposals will be consulted on fully.

Revalidation with the GPhC is an annual requirement for every pharmacy professional to renew their registration and continue practising in Great Britain.

“It’s one of the ways that we work with you to strengthen public confidence in pharmacy,” the Council said.

The GPhC revalidation framework was introduced five years ago. Since then, the pharmacy sector has evolved rapidly, with new service models.

The Council wants to ensure that the current revalidation process remains effective and continues to meet the needs of both professionals and the public.

This survey is open now and will close on 8 September 2024.

Recently, the GPhC revised the routes to registration for internationally-qualified pharmacists who want to practise in Great Britain, following feedback from stakeholders.

It proposed one single route to registration for all non-European Economic Area (EEA)  or European Free Trade Association (EFTA) internationally-qualified pharmacists, reducing the process from two years to one.

This one-year programme will include both university study and in-practice training.

More For You

​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less